Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Clasificación en acciones #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Precio por acción
$152.63
Capitalización bursátil
$376.97B
Cambio (1 día)
12.65%
Cambio (1 año)
79.71%
País
US
Comercio Merck & Co., Inc. (MRK)

Categoría

EPS de Merck & Co., Inc. (MRK)
EPS a fecha de June 2026 TTM: $1.26
Según los últimos informes financieros y el precio de las acciones de Merck & Co., Inc., el EPS actual de la empresa (TTM) es $1.26. Al final del año 2024, la empresa tenía un EPS de $6.76 un aumento con respecto a al EPS de 2023, que fue de $0.14.
Historial de EPS de Merck & Co., Inc. desde 2000 hasta 2026
EPS al final de cada año
Año EPS Cambiar
2026 (TTM) $1.26 -82.69%
2025 $7.28 7.69%
2024 $6.76 4,728.57%
2023 $0.14 -97.56%
2022 $5.73 11.05%
2021 $5.16 84.95%
2020 $2.79 -27.34%
2019 $3.84 60.00%
2018 $2.40 152.63%
2017 $0.95 -54.11%
2016 $2.07 29.38%
2015 $1.60 -61.90%
2014 $4.20 180.00%
2013 $1.50 -31.82%
2012 $2.20 6.80%
2011 $2.06 635.71%
2010 $0.28 -93.25%
2009 $4.15 13.70%
2008 $3.65 -450.96%
2007 $-1.04 -150.98%
2006 $2.04 -3.32%
2005 $2.11 -19.77%
2004 $2.63 -11.45%
2003 $2.97 -6.31%
2002 $3.17 -0.31%
2001 $3.18 7.43%
2000 $2.96 0.00%
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
$29.85 2,269.05%
US
$8.65 586.51%
US
$3.55 181.75%
US
$20.39 1,518.17%
CH
$7.19 470.63%
CH